Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelly A McNeil

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Human Vaccines & Immunotherapeutics|July 11, 2013
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparisonDavid W Scheifele, Shelly A McNeil, Brian J Ward, et al.
The Lancet. Infectious Diseases|August 11, 2019
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trialKathleen M Mullane, Vicki A Morrison, Luis H Camacho, et al.
Vaccine|March 8, 2012
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulationsAmeneh Khatami, Matthew D Snape, Elizabeth Davis, et al.
Vaccine|April 3, 2019
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trialsMarta López-Fauqued, Laura Campora, Frédérique Delannois, et al.
Open Forum Infectious Diseases|January 12, 2023
Burden of Severe Illness Associated With Laboratory-Confirmed Influenza in Adults Aged 50-64 Years, 2010-2011 to 2016-2017Philip Kim, Brenda Coleman, Jeffrey C Kwong, et al.
Journal of the Canadian Association of Gastroenterology|September 3, 2021
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated VaccinesJennifer L Jones, Frances Tse, Matthew W Carroll, et al.
Gastroenterology|February 22, 2021
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live VaccinesEric I Benchimol, Frances Tse, Matthew W Carroll, et al.
Gastroenterology|August 2, 2021
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated VaccinesJennifer L Jones, Frances Tse, Matthew W Carroll, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteersShelly A McNeil, Scott A Halperin, Joanne M Langley, et al.
Journal of the Canadian Association of Gastroenterology|September 3, 2021
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live VaccinesEric I Benchimol, Frances Tse, Matthew W Carroll, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Human Vaccines & Immunotherapeutics|July 11, 2013
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparisonDavid W Scheifele, Shelly A McNeil, Brian J Ward, et al.
The Lancet. Infectious Diseases|August 11, 2019
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trialKathleen M Mullane, Vicki A Morrison, Luis H Camacho, et al.
Vaccine|March 8, 2012
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulationsAmeneh Khatami, Matthew D Snape, Elizabeth Davis, et al.
Vaccine|April 3, 2019
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trialsMarta López-Fauqued, Laura Campora, Frédérique Delannois, et al.
Open Forum Infectious Diseases|January 12, 2023
Burden of Severe Illness Associated With Laboratory-Confirmed Influenza in Adults Aged 50-64 Years, 2010-2011 to 2016-2017Philip Kim, Brenda Coleman, Jeffrey C Kwong, et al.
Journal of the Canadian Association of Gastroenterology|September 3, 2021
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated VaccinesJennifer L Jones, Frances Tse, Matthew W Carroll, et al.
Gastroenterology|February 22, 2021
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live VaccinesEric I Benchimol, Frances Tse, Matthew W Carroll, et al.
Gastroenterology|August 2, 2021
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated VaccinesJennifer L Jones, Frances Tse, Matthew W Carroll, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteersShelly A McNeil, Scott A Halperin, Joanne M Langley, et al.
Journal of the Canadian Association of Gastroenterology|September 3, 2021
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live VaccinesEric I Benchimol, Frances Tse, Matthew W Carroll, et al.
Pageof 11